Nicole M. Kettner

1.6k total citations · 1 hit paper
19 papers, 1.0k citations indexed

About

Nicole M. Kettner is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Endocrine and Autonomic Systems. According to data from OpenAlex, Nicole M. Kettner has authored 19 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pulmonary and Respiratory Medicine, 8 papers in Oncology and 7 papers in Endocrine and Autonomic Systems. Recurrent topics in Nicole M. Kettner's work include Advanced Breast Cancer Therapies (11 papers), Circadian rhythm and melatonin (7 papers) and Cancer-related Molecular Pathways (5 papers). Nicole M. Kettner is often cited by papers focused on Advanced Breast Cancer Therapies (11 papers), Circadian rhythm and melatonin (7 papers) and Cancer-related Molecular Pathways (5 papers). Nicole M. Kettner collaborates with scholars based in United States and South Korea. Nicole M. Kettner's co-authors include Loning Fu, David D. Moore, Choogon Lee, Arun Sreekumar, Nagireddy Putluri, Cristian Coarfa, Milton J. Finegold, Kelly K. Hunt, Khandan Keyomarsi and Akshara Singareeka Raghavendra and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Cell and Cell Metabolism.

In The Last Decade

Nicole M. Kettner

19 papers receiving 1.0k citations

Hit Papers

Circadian Homeostasis of Liver Metabolism Suppresses Hepa... 2016 2026 2019 2022 2016 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Circadian Homeostasis of Liver Metabolism Suppresses Hepatocarcinogenesis
    2016 364 citations Nicole M. Kettner, Milton J. Finegold et al. Cancer Cell profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nicole M. Kettner United States 9 640 464 189 124 101 19 1.0k
Hidenori Shirai Japan 13 514 0.8× 359 0.8× 234 1.2× 91 0.7× 38 0.4× 18 858
Karen K. Kuropatwinski United States 15 811 1.3× 415 0.9× 389 2.1× 146 1.2× 269 2.7× 19 1.4k
Jeongkyung Lee United States 20 484 0.8× 419 0.9× 731 3.9× 156 1.3× 79 0.8× 26 1.5k
Gabriele Sulli United States 5 560 0.9× 507 1.1× 527 2.8× 133 1.1× 57 0.6× 6 1.2k
Tripp Frasch United States 12 794 1.2× 269 0.6× 308 1.6× 59 0.5× 21 0.2× 14 1.1k
Yukako Kuramoto Japan 13 307 0.5× 234 0.5× 168 0.9× 46 0.4× 88 0.9× 18 652
Jacob G. Smith United States 13 359 0.6× 305 0.7× 239 1.3× 109 0.9× 25 0.2× 20 784
Manashree Damle United States 13 281 0.4× 290 0.6× 338 1.8× 78 0.6× 94 0.9× 17 758
Fang Zou China 14 429 0.7× 338 0.7× 196 1.0× 41 0.3× 120 1.2× 25 1.0k
Taro Katsuno Japan 8 162 0.3× 322 0.7× 194 1.0× 62 0.5× 68 0.7× 9 722

Countries citing papers authored by Nicole M. Kettner

Since Specialization
Citations

This map shows the geographic impact of Nicole M. Kettner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicole M. Kettner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicole M. Kettner more than expected).

Fields of papers citing papers by Nicole M. Kettner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicole M. Kettner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicole M. Kettner. The network helps show where Nicole M. Kettner may publish in the future.

Co-authorship network of co-authors of Nicole M. Kettner

This figure shows the co-authorship network connecting the top 25 collaborators of Nicole M. Kettner. A scholar is included among the top collaborators of Nicole M. Kettner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicole M. Kettner. Nicole M. Kettner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Raghavendra, Akshara Singareeka, Nicole M. Kettner, Danielle Kwiatkowski, et al.. (2025). Phase I trial of hydroxychloroquine to enhance palbociclib and letrozole efficacy in ER+/HER2− breast cancer. npj Breast Cancer. 11(1). 7–7. 4 indexed citations
2.
Luo, Linjie, Peng Yang, Sofia Mastoraki, et al.. (2025). Single-cell RNA sequencing identifies molecular biomarkers predicting late progression to CDK4/6 inhibition in patients with HR+/HER2- metastatic breast cancer. Molecular Cancer. 24(1). 48–48. 7 indexed citations
3.
Luo, Linjie, Juliana Navarro-Yepes, Tuyen Bui, et al.. (2024). Abstract PO1-18-05: Combination treatment with CDK2 inhibitor (BLU-222) and either palbociclib or ribociclib is synergistic in pre-clinical models of CDK4/6 inhibitor-resistant breast cancer. Cancer Research. 84(9_Supplement). PO1–18. 1 indexed citations
4.
5.
Nguyen, Tuyen Duong Thanh, Tuyen Bui, Rossana Lazcano, et al.. (2023). Sequential Targeting of Retinoblastoma and DNA Synthesis Pathways Is a Therapeutic Strategy for Sarcomas That Can Be Monitored in Real Time. Cancer Research. 83(6). 939–955. 3 indexed citations
6.
Navarro-Yepes, Juliana, Nicole M. Kettner, Xiayu Rao, et al.. (2023). Abemaciclib Is Effective in Palbociclib-Resistant Hormone Receptor–Positive Metastatic Breast Cancers. Cancer Research. 83(19). 3264–3283. 24 indexed citations
7.
Luo, Linjie, Yan Wang, Sofia Mastoraki, et al.. (2023). Abstract 4346: TFF1 and TFF3 predict response to CDK4/6 inhibitors in breast cancer patients. Cancer Research. 83(7_Supplement). 4346–4346. 1 indexed citations
8.
Ha, Min Jin, Akshara Singareeka Raghavendra, Nicole M. Kettner, et al.. (2022). Palbociclib plus endocrine therapy significantly enhances overall survival of HR+/HER2− metastatic breast cancer patients compared to endocrine therapy alone in the second‐line setting: A large institutional study. International Journal of Cancer. 150(12). 2025–2037. 27 indexed citations
9.
10.
Kettner, Nicole M., Tuyen Bui, Min Jin Ha, et al.. (2020). Abstract P6-04-12: STAT3 as a therapeutic target in estrogen receptor positive breast cancer patients refractory to CDK4/6 inhibition. Cancer Research. 80(4_Supplement). P6–4. 1 indexed citations
11.
Navarro-Yepes, Juliana, Xian Chen, Tuyen Bui, et al.. (2020). Abstract PD2-05: Differential mechanisms of acquired resistance to abemaciclib versus palbociclib reveal novel therapeutic strategies for CDK4/6 therapy-resistant breast cancers. Cancer Research. 80(4_Supplement). PD2–5. 4 indexed citations
12.
Kettner, Nicole M., Milton J. Finegold, Cristian Coarfa, et al.. (2016). Circadian Homeostasis of Liver Metabolism Suppresses Hepatocarcinogenesis. Cancer Cell. 30(6). 909–924. 364 indexed citations breakdown →
13.
Stashi, Erin, Bokai Zhu, Kimal Rajapakshe, et al.. (2016). Genetic and Environmental Models of Circadian Disruption Link SRC-2 Function to Hepatic Pathology. Journal of Biological Rhythms. 31(5). 443–460. 20 indexed citations
14.
Wu, Nan, Kang Ho Kim, Ying Zhou, et al.. (2016). Small Heterodimer Partner (NR0B2) Coordinates Nutrient Signaling and the Circadian Clock in Mice. Molecular Endocrinology. 30(9). 988–995. 11 indexed citations
15.
Kettner, Nicole M., et al.. (2015). Circadian Dysfunction Induces Leptin Resistance in Mice. Cell Metabolism. 22(3). 448–459. 207 indexed citations
16.
Kettner, Nicole M., et al.. (2014). Circadian gene variants in cancer. Annals of Medicine. 46(4). 208–220. 93 indexed citations
17.
Stashi, Erin, Rainer B. Lanz, Jianqiang Mao, et al.. (2014). SRC-2 Is an Essential Coactivator for Orchestrating Metabolism and Circadian Rhythm. Cell Reports. 6(4). 633–645. 64 indexed citations
18.
Fu, Loning & Nicole M. Kettner. (2013). The Circadian Clock in Cancer Development and Therapy. Progress in molecular biology and translational science. 119. 221–282. 183 indexed citations
19.
Geyskes, G. G., et al.. (1986). Comparison of enalapril and propranolol in essential hypertension. European Journal of Clinical Pharmacology. 29(5). 511–516. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hidenori Shirai Breakdown of academic impact, for papers by Karen K. Kuropatwinski Breakdown of academic impact, for papers by Jeongkyung Lee Breakdown of academic impact, for papers by Gabriele Sulli Breakdown of academic impact, for papers by Tripp Frasch Breakdown of academic impact, for papers by Yukako Kuramoto Breakdown of academic impact, for papers by Jacob G. Smith Breakdown of academic impact, for papers by Manashree Damle Breakdown of academic impact, for papers by Fang Zou Breakdown of academic impact, for papers by Taro Katsuno
Rankless by CCL
2026